Avapritinib not recommended for unresectable or metastatic gastrointestinal stromal tumours

Avapritinib not deemed cost-effective, according to NICE draft guidance.

Please sign in or register for FREE

1 Comment

Go to the profile of Wayne Sefton Davis
Wayne Sefton Davis 3 months ago

Very sad. How do you say that extension of life is not cost-effective? What price do you put on life?